JNJ-89402638 Phase 2 Study Initiated for Metastatic Colorectal and Gastric Cancers
A Phase 2 study is underway to assess the safety and optimal administration of JNJ-89402638 in mCRC and mGAC patients.
Indication
Clinical and regulatory intelligence for Metastatic Colorectal and Gastric Cancer with 1 indexed intelligence signal across regulatory, clinical, competitive, and market developments.
No catalysts indexed for this entity yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.